BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Alliance of ALS/MND Associations - ECPv6.8.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.als-mnd.org
X-WR-CALDESC:Events for International Alliance of ALS/MND Associations
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260820T110000
DTEND;TZID=America/Toronto:20260820T120000
DTSTAMP:20261020T044915
CREATED:20260729T204217Z
LAST-MODIFIED:20260807T113621Z
UID:19946-1787223600-1787227200@www.als-mnd.org
SUMMARY:Les Turner ALS Foundation: ALS-FTD Clinicopathological Overlap
DESCRIPTION:Les Turner ALS Foundation: ALS-FTD Clinicopathological Overlap \nALS and frontotemporal dementia (FTD) are increasingly understood to share underlying biological connections\, and some people living with ALS may also experience changes in thinking\, behavior\, or personality. Join Dr. David Irwin from Penn Medicine\, as he explores the relationship between ALS and ALS-FTD\, explaining what current research tells us about how these conditions overlap. This session will help you understand what cognitive and behavioral changes to watch for\, how they may show up over the course of the disease\, and what this means for care and support planning. \nAbout the Speaker: Dr. David Irwin is the clinical director of the Penn Frontotemporal Degeneration Center and PI of the Penn Digital Neuropathology Lab at the University of Pennsylvania Perelman School of medicine. He has dual training in cognitive neurology and neuropathology and his lab focuses on integrating human brain histopathology and molecular techniques with antemortem clinical data\, with the overall goal of identifying therapeutic targets and markers of disease progression that can serve as endpoints in treatment trials for FTD\, ALS\, LBD\, AD and related neurodegenerative disorders. \nRegister now
URL:https://www.als-mnd.org/event/als-ftd-clinicopathological-overlap/
ORGANIZER;CN="Les Turner ALS Foundation":MAILTO:info@lesturnerals.org
END:VEVENT
END:VCALENDAR